AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Apr 17, 2015
29828_dirs_2015-04-17_a982b7e7-9a18-4360-b142-5fca8aab5a46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-04-15
Reporting Person: BISCHOFBERGER NORBERT W (EVP, R&D and CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-15 | Common Stock | M | 70000 | $20.74 | Acquired | 235168 | Direct |
| 2015-04-15 | Common Stock | S | 10239 | $103.0597 | Disposed | 224929 | Direct |
| 2015-04-15 | Common Stock | S | 59761 | $103.9708 | Disposed | 165168 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-15 | Non-Qualified Stock Option (right to buy) | $20.74 | M | 70000 | Disposed | 2017-05-08 | Common Stock (70000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $102.47 to $103.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $103.48 to $104.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.